Skip to Content

Join the 'Hepatitis B' group to help and get support from people like you.

Hepatitis B News

Related terms: Chronic Hepatitis B, Hepatitis B, Chronic, HBV

Boy Who Died 450 Years Ago Gives Clues to Hepatitis Research

Posted 5 Jan 2018 by Drugs.com

THURSDAY, Jan. 4, 2018 – The mummified remains of an Italian boy who died 450 years ago suggest the hepatitis B virus has infected humans for centuries. The child died in the 16th century. And prior testing suggested smallpox killed him. But a new analysis evaluated DNA samples from the boy's bone and skin. This second look led investigators to conclude the killer was actually hepatitis B. ...

Boy Who Died 450 Years Ago Gives Clues to Hepatitis Research

Posted 5 Jan 2018 by Drugs.com

THURSDAY, Jan. 4, 2018 – The mummified remains of an Italian boy who died 450 years ago suggest the hepatitis B virus has infected humans for centuries. The child died in the 16th century. And prior testing suggested smallpox killed him. But a new analysis evaluated DNA samples from the boy's bone and skin. This second look led investigators to conclude the killer was actually hepatitis B. ...

Dynavax Announces FDA Approval of Heplisav-B for Prevention of Hepatitis B in Adults

Posted 14 Nov 2017 by Drugs.com

BERKELEY, CA – (Marketwired) – November 9, 2017 – Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that the U.S. Food and Drug Administration (FDA) has approved Heplisav-B [Hepatitis B Vaccine, Recombinant (Adjuvanted)] for prevention of infection caused by all known subtypes of hepatitis B virus in adults age 18 years and older. Heplisav-B is the first new hepatitis B vaccine ...

Can Aspirin Stop Liver Cancer in Hepatitis B Patients?

Posted 20 Oct 2017 by Drugs.com

FRIDAY, Oct. 20, 2017 – Daily aspirin may reduce the risk of liver cancer for people with hepatitis B infection, a new study suggests. Hepatitis B virus attacks the liver and can cause cirrhosis and liver cancer. Previous research suggests daily low-dose aspirin therapy may prevent cancer, but there is little clinical evidence on whether regular aspirin use can prevent liver cancer in people ...

Semen Harbors Wide Range of Viruses

Posted 13 Sep 2017 by Drugs.com

WEDNESDAY, Sept. 13, 2017 – Human semen provides a potential hiding place and breeding ground for a host of dangerous viruses, a new evidence review reports. The analysis of current medical literature revealed genetic evidence of 27 infectious viruses found in semen, including dread-inducing agents like Zika, Ebola, Marburg, Lassa fever and chikungunya, along with mumps, Epstein-Barr and chicken ...

Hep B Vaccine Should Be Given Sooner: Pediatricians Group

Posted 28 Aug 2017 by Drugs.com

MONDAY, Aug. 28, 2017 – The first dose of the hepatitis B vaccine should be given to babies within 24 hours of birth, new guidelines from the American Academy of Pediatrics say. Until now, the academy had recommended the vaccine be given by the baby's first checkup. Now, the risk of infection has increased with the ongoing opioid crisis, as more moms are getting infected with hepatitis B and ...

Only About One-Third of Americans Use Condoms: CDC

Posted 10 Aug 2017 by Drugs.com

THURSDAY, Aug. 10, 2017 – Condoms can help prevent pregnancy and the spread of sexually transmitted diseases (STDs), but only about a third of Americans use them, a new federal report shows. "The use of condoms is a public health issue," said report author Casey Copen, a statistician at the U.S. Centers for Disease Control and Prevention's National Center for Health Statistics. "STDs can lead to ...

As U.S. Heroin Use Reaches 20-Year High, Cost to Society Soars

Posted 14 Jun 2017 by Drugs.com

WEDNESDAY, June 14, 2017 – Heroin use cost the United States more than $51 billion in 2015, a new study shows. The financial toll includes heroin-related crime and imprisonment. It also includes treatment for addiction as well as chronic infectious diseases contracted through heroin abuse (such as HIV, hepatitis B and C, and tuberculosis), according to researchers from the University of Illinois ...

Hepatitis Infection May Raise Risk for Parkinson's Disease

Posted 30 Mar 2017 by Drugs.com

THURSDAY, March 30, 2017 – People with the liver infection hepatitis may be at heightened risk of developing Parkinson's disease, a large new study suggests. The study, published online March 29 in Neurology, is the second in the past year to link hepatitis to Parkinson's. Specifically, the new study found that people who'd been infected with hepatitis B or C were 51 percent to 76 percent more ...

Better Efforts Could Help Rid the U.S. of Hepatitis B, C: Report

Posted 28 Mar 2017 by Drugs.com

TUESDAY, March 28, 2017 – Improved prevention, screening and treatment could help eliminate hepatitis B and C as serious public health problems in the United States and save nearly 90,000 lives by 2030, according to a new report. About 1.3 million people in the United States have chronic hepatitis B and about 2.7 million have chronic hepatitis C. These infections cause about 80 percent of liver ...

Use of Needle Exchange Programs Up Dramatically in 10 Years: CDC

Posted 30 Nov 2016 by Drugs.com

WEDNESDAY, Nov. 30, 2016 – Although there was a significant increase in the use of syringe services programs (SSPs) – more commonly known as needle exchange programs – across the United States over the past decade, many injection drug users don't always use sterile needles, a federal government report says. Previously used needles put drug users at risk for infectious diseases such as HIV and ...

FDA Approves Gilead’s Vemlidy (tenofovir alafenamide) for the Treatment of Chronic Hepatitis B Virus Infection

Posted 15 Nov 2016 by Drugs.com

FOSTER CITY, Calif.--(BUSINESS WIRE)--Nov. 10, 2016-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved Vemlidy (tenofovir alafenamide, TAF) 25mg, a once-daily treatment for adults with chronic hepatitis B virus (HBV) infection with compensated liver disease. Vemlidy has a boxed warning in its product label regarding the risks of ...

Robotic Surgical Tools Tough to Keep Clean

Posted 1 Nov 2016 by Drugs.com

TUESDAY, Nov. 1, 2016 – Even with repeated cleanings, it's virtually impossible to remove all contamination from robotic surgical instruments, a new study suggests. "One of the top priorities for hospitals is to treat patients safely and with minimal risk of infection," said study author Yuhei Saito, an assistant professor at the University of Tokyo Hospital in Japan. "Our results show that ...

FDA Medwatch Alert: Direct-Acting Antivirals for Hepatitis C: Drug Safety Communication - Risk of Hepatitis B Reactivating

Posted 10 Oct 2016 by Drugs.com

ISSUE: The FDA is warning about the risk of hepatitis B virus (HBV) becoming an active infection again in any patient who has a current or previous infection with HBV and is treated with certain direct-acting antiviral (DAA) medicines for hepatitis C virus. In a few cases, HBV reactivation in patients treated with DAA medicines resulted in serious liver problems or death. HBV reactivation usually ...

Tips for Avoiding Back-to-School Germs, Illnesses

Posted 23 Sep 2016 by Drugs.com

FRIDAY, Sept. 23, 2016 – Kids and germs seem to go together like peanut butter and jelly. But, there are ways that parents can help protect their kids from the usual barrage of back-to-school illnesses, a health expert says. Make sure children get plenty of sleep and eat a well balanced diet, advises Jacqueline Stout-Aguilar. She's a registered nurse and an assistant professor at the Texas A&M ...

Page 1 2 Next

Ask a Question

Further Information

Related Condition Support Groups

Exposure to Hepatitis B Virus, Infectious Hepatitis

Related Drug Support Groups

Baraclude, Viread, lamivudine, tenofovir, Pegasys, interferon alfa-2b, entecavir, Vemlidy, peginterferon alfa-2a, view more... Intron A, Epivir, PegIntron, Tyzeka, adefovir, Epivir-HBV, tenofovir alafenamide, telbivudine, peginterferon alfa-2b, Hepsera